Spectral Ai, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
Spectral AI, an AI medical diagnostics company, reported a reduced net loss in 2025 but a decline in revenue, while advancing its DeepView System towards commercialization with key regulatory approvals and significant government funding.
NASDAQ
Spectral AI's 2024 annual report reveals a focus on DeepView System development, UKCA marking achievement, and reliance on government funding, with a net loss of $15.3 million.
NASDAQ
Spectral AI, Inc. released its 2023 annual report, detailing advancements in its DeepView System and financial performance, including significant government funding and regulatory milestones.